Latest Yield News

Kore Potash made steady progress on its Kola Potash Project in Q1 2026, completing key marine and topographic studies while navigating design revisions and ongoing financing talks. The company’s formal sale process continues with one bidder remaining active and cash reserves at US$8.3 million.

Bindi Metals has confirmed bonanza-grade gold mineralisation at its Ravni Gold Project in Serbia, defining a 3 km high-grade corridor and preparing for maiden drilling with a preferred contractor in place.

Gibb River Diamonds (ASX:GIB) has completed mining and processing at its Neta JV within the Edjudina Gold Project, generating over 5,200 ounces of gold and receiving a $7 million profit share. The company is progressing exploration on a new lease near Neta and maintains a strong cash position to support further growth.

Strata Minerals delivered strong maiden drilling results at its Zelica Gold Project, confirming consistent shallow high-grade gold mineralisation over a 1km strike. The company consolidated its landholding with the acquisition of Zelica South, extending the gold corridor to 10km and commencing follow-up exploration.

Accelerate Resources (ASX: AX8) has made significant strides in its dual-growth strategy, uncovering multiple gold mineralised corridors at Balagundi and defining a new high-grade manganese hub at Woodie Woodie North during the March 2026 quarter.

Clara Resources has completed acquisition of the Mareeba Gold Project, initiating modern exploration and refocusing its portfolio on Queensland gold assets while securing fresh capital and leadership changes.

Marquee Resources has significantly increased its Mt Clement inferred antimony resource and is advancing drilling and strategic partnerships to develop its flagship project.

Pivotal Metals has kicked off drilling at its Belleterre projects and reported promising metallurgical testwork at Horden Lake, supporting an upcoming resource update and scoping study.

Green & Gold Minerals completed the Herberton Conductor Metals Project acquisition, unveiling high-grade copper, silver, indium, and rare earth discoveries while maintaining a strong cash position for 2026 exploration.

Alexium International Group has boosted sales to $1.03 million following its Microtek Laboratories acquisition, shifting focus to manufacturing-led growth and expanding its flame-retardant and thermal regulation product lines.

Dimerix has completed adult patient recruitment in its Phase 3 ACTION3 trial for DMX-200, with a blinded review confirming the study remains statistically powered to demonstrate treatment efficacy. The company also appointed a new CFO and is negotiating up to US$50 million in non-dilutive funding.

Percheron Therapeutics has secured $2.2 million through an entitlement offer to fund the next stage of its HMBD-002 oncology program, with manufacturing underway and key data presentations lined up at major cancer conferences.